Available alternative FDA-approved therapies include estrogen, Evista® (raloxifene) and Prolia® (denosumab).
Unyango olulolunye olukhoyo noluvunyiweyo yiFDA luquka i-estrogen, Evista® (raloxifene) kunye neProlia® (denosumab).